Mesoporous Silica Nanoparticles as an Ideal Platform for Cancer Immunotherapy: Recent Advances and Future Directions.
Open Access
- 3 May 2024
- journal article
- review article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 13 (20) , e2400323
Abstract
Cancer immunotherapy recently transforms the traditional approaches against various cancer malignancies. Immunotherapy includes systemic and local treatments to enhance immune responses against cancer and involves strategies such as immune checkpoints, cancer vaccines, immune modulatory agents, mimetic antigen‐presenting cells, and adoptive cell therapy. Despite promising results, these approaches still suffer from several limitations including lack of precise delivery of immune‐modulatory agents to the target cells and off‐target toxicity, among others, that can be overcome using nanotechnology. Mesoporous silica nanoparticles (MSNs) are investigated to improve various aspects of cancer immunotherapy attributed to the advantageous structural features of this nanomaterial. MSNs can be engineered to alter their properties such as size, shape, porosity, surface functionality, and adjuvanticity. This review explores the immunological properties of MSNs and the use of MSNs as delivery vehicles for immune‐adjuvants, vaccines, and mimetic antigen‐presenting cells (APCs). The review also details the current strategies to remodel the tumor microenvironment to positively reciprocate toward the anti‐tumor immune cells and the use of MSNs for immunotherapy in combination with other anti‐tumor therapies including photodynamic/thermal therapies to enhance the therapeutic effect against cancer. Last, the present demands and future scenarios for the use of MSNs for cancer immunotherapy are discussed.Keywords
Funding Information
- National Cancer Center (R01CA263897)
This publication has 239 references indexed in Scilit:
- Engineered Mesenchymal Stem Cells as a Biotherapy Platform for Targeted Photodynamic Immunotherapy of Breast CancerAdvanced Healthcare Materials, 2022
- Robust Nanovaccine Based on Polydopamine‐Coated Mesoporous Silica Nanoparticles for Effective Photothermal‐Immunotherapy Against MelanomaAdvanced Functional Materials, 2021
- iRGD Modified Chemo‐immunotherapeutic Nanoparticles for Enhanced Immunotherapy against GlioblastomaAdvanced Functional Materials, 2018
- Dendritic Mesoporous Silica Nanoparticles for pH‐Stimuli‐Responsive Drug Delivery of TNF‐AlphaAdvanced Healthcare Materials, 2017
- Understanding the Effect of Surface Chemistry of Mesoporous Silica Nanorods on Their Vaccine Adjuvant PotencyAdvanced Healthcare Materials, 2017
- Degradability and Clearance of Silicon, Organosilica, Silsesquioxane, Silica Mixed Oxide, and Mesoporous Silica NanoparticlesAdvanced Materials, 2017
- Comprehensive Mechanism Analysis of Mesoporous‐Silica‐Nanoparticle‐Induced Cancer ImmunotherapyAdvanced Healthcare Materials, 2016
- Facile and Scalable Synthesis of Tailored Silica “Nanorattle” StructuresAdvanced Materials, 2009
- Colloidal Suspensions of Nanometer‐Sized Mesoporous SilicaAdvanced Functional Materials, 2007
- Nanoscale Materials with Mesostructured InteriorsAdvanced Materials, 2001